| No. 18-127 | |
| Title: | Amgen Inc., et al., Petitioners v. Sanofi, et al. |
| Docketed: | July 27, 2018 |
| Linked with 17A1262 | |
| Lower Ct: | United States Court of Appeals for the Federal Circuit |
| Case Numbers: | (2017-1480) |
| Decision Date: | October 5, 2017 |
| Rehearing Denied: | February 23, 2018 |
| Date | Proceedings and Orders |
| May 11 2018 | Application (17A1262) to extend the time to file a petition for a writ of certiorari from May 24, 2018 to July 23, 2018, submitted to The Chief Justice. |
| Main DocumentLower Court Orders/OpinionsOtherProof of Service | |
| May 14 2018 | Application (17A1262) granted by The Chief Justice extending the time to file until July 23, 2018. |
| Jul 23 2018 | Petition for a writ of certiorari filed. (Response due August 27, 2018) |
| PetitionCertificate of Word CountProof of Service | |
| Aug 27 2018 | Brief amici curiae of Bristol-Myers Squibb Company, Morphosys AG, Bavarian Nordic A/S, and UCB Biopharma SPRL filed. |
| Main DocumentCertificate of Word CountProof of Service | |
| Sep 12 2018 | DISTRIBUTED for Conference of 10/5/2018. |
| Sep 18 2018 | Response Requested. (Due October 18, 2018) |
| Sep 20 2018 | Motion to extend the time to file a response is granted and the time is extended to and including November 19, 2018 |
| Sep 20 2018 | Motion to extend the time to file a response from October 18, 2018 to November 17, 2018, submitted to The Clerk. |
| Main Document | |
| Nov 19 2018 | Brief of respondents Sanofi, et al. in opposition filed. |
| Main DocumentCertificate of Word CountProof of Service | |
| Dec 04 2018 | Reply of petitioners Amgen Inc., et al. filed. (Distributed) |
| Main DocumentCertificate of Word CountProof of Service | |
| Dec 05 2018 | DISTRIBUTED for Conference of 1/4/2019. |
| Jan 07 2019 | Petition DENIED. |
| NAME | ADDRESS | PHONE |
| Attorneys for Petitioners | ||
| Jeffrey Alan Lamken Counsel of Record | MoloLamken LLP The Watergate, Suite 660 600 New Hampshire Ave., N.W. Washington, DC 20037 jlamken@mololamken.com | 2025562010 |
| Party name: Amgen Inc., et al. | ||
| Attorneys for Respondents | ||
| Paul D. Clement Counsel of Record | Kirkland & Ellis LLP 655 Fifteenth Street, NW Washington, DC 20005 paul.clement@kirkland.com | |
| Party name: Sanofi, et al. | ||
| Other | ||
| Jorge Alberto Goldstein Counsel of Record | Sterne, Kessler, Goldstein & Fox, P.L.L.C. 1100 New York Avenue, NW Washington, DC 20005 jgold@sternekessler.com | 202-772-8609 |
| Party name: Bristol-Myers Squibb Company, Morphosys AG, Bavarian Nordic A/S, and UCB Biopharma SPRL | ||